BOT 1.33% 37.0¢ botanix pharmaceuticals ltd

BOT - Anything but charting, page-9088

  1. 532 Posts.
    lightbulb Created with Sketch. 150
    Couldn't agree more the right marketing, sales of Sofdra could be through the rood.

    Another social media promotion on Threads and Instagram by Dr Waleed Alsalhi, about BOT's Sofdra, FDA New Treatment for Primary Axillary Hyperhidrosis, in Arabic. A great promotion for potential market targeting in the Middle Eastern Community/Countries.

    Dr Waleed Alsalhi, Biography
    * Consultant Dermatologist Department at Makkah University, KSA Hairs & Nails fellowship in Miami University, FL, USA.
    * Triple board certified consultant dermatologist
    * The Saudi & Arab Boards in Dermatology & Venereology
    * European Board of dermatology & venereology
    * Assistant Professor in Dermatology, Collage of Medicine, AI-Majmaah University

    ps. unable to upload the pictures from Threads and Twitter to here, please search Dr Waleed Alsalhi o
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.005(1.33%)
Mkt cap ! $669.7M
Open High Low Value Volume
37.5¢ 39.0¢ 37.0¢ $1.603M 4.223M

Buyers (Bids)

No. Vol. Price($)
4 378157 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
37.5¢ 98000 5
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.